ProfileGDS4814 / ILMN_1791067
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 88% 85% 85% 88% 86% 87% 85% 88% 87% 86% 88% 88% 88% 87% 87% 88% 87% 87% 89% 88% 85% 89% 88% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)322.14388
GSM780708Untreated after 4 days (C2_1)241.39185
GSM780709Untreated after 4 days (C3_1)229.67585
GSM780719Untreated after 4 days (C1_2)339.24388
GSM780720Untreated after 4 days (C2_2)264.5686
GSM780721Untreated after 4 days (C3_2)287.23487
GSM780710Trastuzumab treated after 4 days (T1_1)240.00785
GSM780711Trastuzumab treated after 4 days (T2_1)319.288
GSM780712Trastuzumab treated after 4 days (T3_1)276.19187
GSM780722Trastuzumab treated after 4 days (T1_2)247.79186
GSM780723Trastuzumab treated after 4 days (T2_2)326.2388
GSM780724Trastuzumab treated after 4 days (T3_2)329.35388
GSM780713Pertuzumab treated after 4 days (P1_1)318.19288
GSM780714Pertuzumab treated after 4 days (P2_1)274.03687
GSM780715Pertuzumab treated after 4 days (P3_1)293.65587
GSM780725Pertuzumab treated after 4 days (P1_2)315.94588
GSM780726Pertuzumab treated after 4 days (P2_2)293.5587
GSM780727Pertuzumab treated after 4 days (P3_2)280.22187
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)376.60289
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)320.31488
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)228.89385
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)345.82389
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)324.48988